These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 18835181)
41. Curcumin inhibition of integrin (alpha6beta4)-dependent breast cancer cell motility and invasion. Kim HI; Huang H; Cheepala S; Huang S; Chung J Cancer Prev Res (Phila); 2008 Oct; 1(5):385-91. PubMed ID: 19138983 [TBL] [Abstract][Full Text] [Related]
42. Focal adhesion kinase regulates the phosphorylation protein tyrosine phosphatase-α at Tyr789 in breast cancer cells. Fang XQ; Liu XF; Yao L; Chen CQ; Lin JF; Gu ZD; Ni PH; Zheng XM; Fan QS Mol Med Rep; 2015 Jun; 11(6):4303-8. PubMed ID: 25625869 [TBL] [Abstract][Full Text] [Related]
43. Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells. Juan SH; Lee JL; Ho PY; Lee YH; Lee WS Eur J Pharmacol; 2006 Jan; 530(1-2):1-8. PubMed ID: 16359657 [TBL] [Abstract][Full Text] [Related]
44. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway. Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522 [TBL] [Abstract][Full Text] [Related]
45. Spreading by snail (Lymnaea stagnalis) defence cells is regulated through integrated PKC, FAK and Src signalling. Walker AJ; Lacchini AH; Sealey KL; Mackintosh D; Davies AJ Cell Tissue Res; 2010 Jul; 341(1):131-45. PubMed ID: 20512591 [TBL] [Abstract][Full Text] [Related]
47. Retinoic acid induces nuclear FAK translocation and reduces breast cancer cell adhesion through Moesin, FAK, and Paxillin. Sanchez AM; Shortrede JE; Vargas-Roig LM; Flamini MI Mol Cell Endocrinol; 2016 Jul; 430():1-11. PubMed ID: 27130522 [TBL] [Abstract][Full Text] [Related]
48. Marine Natural Product Bis-indole Alkaloid Caulerpin: Chemistry and Biology. Lunagariya J; Bhadja P; Zhong S; Vekariya R; Xu S Mini Rev Med Chem; 2019; 19(9):751-761. PubMed ID: 28971770 [TBL] [Abstract][Full Text] [Related]
49. Anthocyanidins, novel FAK inhibitors, attenuate PDGF-BB-induced aortic smooth muscle cell migration and neointima formation. Son JE; Lee E; Jung SK; Kim JE; Oak MH; Lee KW; Lee HJ Cardiovasc Res; 2014 Mar; 101(3):503-12. PubMed ID: 24363205 [TBL] [Abstract][Full Text] [Related]
50. In-vitro antiproliferative activities and kinase inhibitory potencies of meridianin derivatives. Rossignol E; Debiton E; Fabbro D; Moreau P; Prudhomme M; Anizon F Anticancer Drugs; 2008 Sep; 19(8):789-92. PubMed ID: 18690090 [TBL] [Abstract][Full Text] [Related]
51. Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms. Bryant P; Zheng Q; Pumiglia K Mol Cell Biol; 2006 Jun; 26(11):4201-13. PubMed ID: 16705171 [TBL] [Abstract][Full Text] [Related]
52. Calyculin-A induces focal adhesion assembly and tyrosine phosphorylation of p125(Fak), p130(Cas), and paxillin in Swiss 3T3 cells. Leopoldt D; Yee HF; Rozengurt E J Cell Physiol; 2001 Jul; 188(1):106-19. PubMed ID: 11382927 [TBL] [Abstract][Full Text] [Related]
53. Design and synthesis of 7H-pyrrolo[2,3-d]pyrimidines as focal adhesion kinase inhibitors. Part 1. Choi HS; Wang Z; Richmond W; He X; Yang K; Jiang T; Sim T; Karanewsky D; Gu XJ; Zhou V; Liu Y; Ohmori O; Caldwell J; Gray N; He Y Bioorg Med Chem Lett; 2006 Apr; 16(8):2173-6. PubMed ID: 16458503 [TBL] [Abstract][Full Text] [Related]
54. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation. Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712 [TBL] [Abstract][Full Text] [Related]
55. Identification of methyl violet 2B as a novel blocker of focal adhesion kinase signaling pathway in cancer cells. Kim H; Kim ND; Lee J; Han G; Sim T Biochem Biophys Res Commun; 2013 Jul; 437(2):319-24. PubMed ID: 23817042 [TBL] [Abstract][Full Text] [Related]
56. Harnessing the Chemistry of the Indole Heterocycle to Drive Discoveries in Biology and Medicine. Norwood VM; Huigens RW Chembiochem; 2019 Sep; 20(18):2273-2297. PubMed ID: 30609199 [TBL] [Abstract][Full Text] [Related]
57. Highly active modulators of indole signaling alter pathogenic behaviors in Gram-negative and Gram-positive bacteria. Minvielle MJ; Eguren K; Melander C Chemistry; 2013 Dec; 19(51):17595-602. PubMed ID: 24243627 [TBL] [Abstract][Full Text] [Related]
58. alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion. Wang D; Chuang HC; Weng SC; Huang PH; Hsieh HY; Kulp SK; Chen CS J Med Chem; 2009 Sep; 52(18):5642-8. PubMed ID: 19708661 [TBL] [Abstract][Full Text] [Related]
59. Collective Synthesis of Sarpagine and Macroline Alkaloid-Inspired Compounds. Aoyama H; Davies C; Liu J; Pahl A; Kirchhoff JL; Scheel R; Sievers S; Strohmann C; Grigalunas M; Waldmann H Chemistry; 2024 Jan; 30(5):e202303027. PubMed ID: 37755456 [TBL] [Abstract][Full Text] [Related]
60. The first total synthesis of dragmacidin d. Garg NK; Sarpong R; Stoltz BM J Am Chem Soc; 2002 Nov; 124(44):13179-84. PubMed ID: 12405846 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]